A retrospective study led by University of Cincinnati Cancer Center researchers showed that a device that acts as a GPS for surgeons to locate and remove breast and lymph node tumors was safe and effective.
FDA approved Keytruda (pembrolizumab) to be used with gemcitabine and cisplatin for locally advanced unresectable or metastatic biliary tract cancer.
FDA has approved Loqtorz (toripalimab-tpzi) with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent, locally advanced nasopharyngeal carcinoma.
AnHeart Therapeutics has entered into an exclusive license agreement with Nippon Kayaku Co., Ltd to market and distribute AnHeart’s lead investigational therapy, taletrectinib, in Japan.
The National Cancer Institute approved the following clinical research studies last month.
Monica Bertagnolli testifies during her Senate Health, Education, Labor and Pensions Committee confirmation hearing to be the next NIH Director, Oct. 18, 2023 Photo credit: Kevin Dietsch/Getty ImagesA Senate Committee Oct. 25 voted 15-6 to advance the confirmation of Monica Bertagnolli to the role of NIH director.
Steven Rosenberg receiving the National Medal of Technology and Innovation from President Biden. The medal is being presented by a military aide (right).Immunotherapy pioneer Steven A. Rosenberg was awarded the National Medal of Technology and Innovation by President Joe Biden.
Nadine J. Barrett was named associate director of community outreach and engagement at Atrium Health Wake Forest Baptist Comprehensive Cancer Center.
Shelley Tworoger, an epidemiologist at Moffitt Cancer Center, was named to two roles at OHSU: head of the Division of Oncological Sciences in the School of Medicine, and associate director for population science at the Knight Cancer Institute.
Elad Sharon was named clinical and translational director of the Immunotherapy Toxicity Service at Dana-Farber Cancer Institute. Sharon will work to build out the research and clinical components of the program.
